T. Rowe Price Investment Management, Inc. 13D and 13G filings for Avanos Medical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 10:47 am Purchase | 2025-03-31 | 13G | Avanos Medical, Inc. AVNS | T. Rowe Price Investment Management, Inc. | 3,757,576 8.200% | 746,264 (+24.78%) | Filing |
| 2025-02-14 09:45 am Purchase | 2024-12-31 | 13G | Avanos Medical, Inc. AVNS | T. Rowe Price Investment Management, Inc. | 3,011,312 6.600% | 644,267 (+27.22%) | Filing |
| 2024-11-14 1:28 pm Purchase | 2024-09-30 | 13G | Avanos Medical, Inc. AVNS | T. Rowe Price Investment Management, Inc. | 2,367,045 5.200% | 2,367,045 (New Position) | Filing |